Enveric Biosciences Inc
(ENVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 42,998 | 48,594 | 36,146 | 20,261 |
| Cost of Goods | N/A | 34,015 | 38,356 | 29,217 | 13,392 |
| Gross Profit | N/A | 8,984 | 10,238 | 6,928 | 6,870 |
| Operating Expenses | 2,297 | 16,145 | 21,490 | 12,526 | 8,055 |
| Operating Income | -2,297 | -7,147 | -10,897 | -5,380 | -794 |
| Interest Expense | 82 | 730 | 575 | 751 | 239 |
| Other Income | -32 | -2,673 | 5 | -394 | 90 |
| Pre-tax Income | -2,411 | -10,549 | -11,467 | -6,525 | -943 |
| Income Tax | N/A | 6,349 | -2,392 | -3,748 | -129 |
| Net Income Continuous | -2,411 | -16,898 | -9,075 | -2,777 | -814 |
| Minority Interests | N/A | N/A | N/A | 3 | N/A |
| Net Income | $-2,411 | $-16,898 | $-9,075 | $-2,781 | $-814 |
| EPS Basic Total Ops | -4,139.59 | -736,846.50 | -0.75 | -0.21 | -0.07 |
| EPS Basic Continuous Ops | -4,103.25 | -638,917.90 | -0.61 | -0.21 | -0.07 |
| EPS Diluted Total Ops | -4,139.59 | -736,846.50 | -0.75 | -0.21 | -0.07 |
| EPS Diluted Continuous Ops | -4,103.25 | -638,917.90 | -0.61 | -0.21 | -0.07 |
| EPS Diluted Before Non-Recurring Items | -101,869.80 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-2,228 | $4,796 | $-7,679 | $-4,019 | $-628 |